Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
It is an investigational medication from Eli Lilly, still in its Phase 3 TRIUMPH trial program
(1 April 2000)
For Parkinson disease research, BPC-157 counteraction of MPTP neurotoxicity is directly relevant
First, patients getting higher-than-intended doses often due to mislabeling or misunderstanding can experience severe nausea, vomiting, dehydration, and require urgent care
US$ 25.06
US$ 24.72
US$ 20.73
US$ 27.83
US$ 21.10
US$ 24.70
US$ 28.03
US$ 24.10
US$ 22.09
US$ 22.47
